Insiders Updates TRDA short interest fall by -6.02%, reflecting positive sentiment Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Entrada Therapeutics
Insiders Updates Entrada Therapeutics Inc [TRDA] Director makes an insider sale of 27,000 shares worth $0.2 million. Entrada Therapeutics Inc’s recently made public that its Director PARMAR KUSH unloaded Company’s shares for reported $0.2 million on Jul
Stock Earnings Potential Price Increase for Entrada Therapeutics Inc (TRDA) After Recent Insider Activity Entrada Therapeutics Inc’s recently made public that its Director PARMAR KUSH unloaded Company’s shares for reported $0.2 million on Jul